Aposense

  • Home
  • About Us
    • Overview
    • Scientific president
    • Team
    • Board of directors
    • Intellectual property
  • Our Technology
  • SirVir
    • Aposense subsidiary in the field of respiratory viral infections
  • ATT-11T: Anti cancer pro-drug
    • On June 1st 2020 Aposense signed an agreement to license out the ATT-11T to Processa Pharmaceuticals
  • News
  • Contact Us


Aposense has signed a definitive agreement with SirVir Ltd. A private company, jointly owned by Aposense, Prof. Roger D. Kornberg, and Access Industries Holdings LLC. SirVir will engage in the development and commercialization of products in the field of treatment of respiratory viral infections, based on the Apo-Si technology developed by the Company

January 8 2019
News
Read More
Aposense

Contact Us

Telephone: + 972.73.239.7600
Fax: +972.3.921.57.14
E-mail: info@aposense.com

Careers

  • משרת עוזר/ת מחקר

    24 Jan 2021

Latest news

  • SirVir Ltd., an Aposense subsidiary in the field of respiratory viral infections announce the fulfillment of a $14M milestone investment

    28 Feb 2021

  • Prof. Roger Kornberg mentions SirVir’s breakthrough results and applicability of the platform in an interview for Ynet.

    7 Jan 2021

  • Aposense enters into an out-licensing agreement with Processa Pharmaceuticals

    1 Jun 2020

Aposense © 2021. Privacy Policy
  • Home
  • About Us
    ▼
    • Overview
    • Scientific president
    • Team
    • Board of directors
    • Intellectual property
  • Our Technology
  • SirVir
    ▼
    • Aposense subsidiary in the field of respiratory viral infections
  • ATT-11T: Anti cancer pro-drug
    ▼
    • On June 1st 2020 Aposense signed an agreement to license out the ATT-11T to Processa Pharmaceuticals
  • News
  • Contact Us
Skip to content
Open toolbar

Accessibility Tools

  • Increase Text
  • Decrease Text
  • Grayscale
  • High Contrast
  • Negative Contrast
  • Light Background
  • Links Underline
  • Readable Font
  • Reset